Colorectal surgery obesity-related morbidity during COVID-19

被引:4
作者
Montorfano, Lisandro [1 ]
Miret, Rafael [1 ]
Rahman, Asad Ur [2 ]
Alonso, Mileydis [1 ]
Maron, David J. [3 ]
Roy, Mayank [1 ]
Ferri, Francisco [1 ]
Bejarano, Pablo [4 ]
Wexner, Steven D. [3 ]
机构
[1] Cleveland Clin Florida, Dept Gen Surg, Weston, FL 33331 USA
[2] Cleveland Clin Florida, Dept Gastroenterol, Weston, FL 33331 USA
[3] Cleveland Clin Florida, Dept Colorectal Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA
[4] Cleveland Clin Florida, Dept Lab Med, Weston, FL 33331 USA
关键词
COVID-19; SARS-CoV-2; coronavirus; Tocilizumab; IL-6; Corticosteroids; Bowel perforation; Colonic perforation; TOCILIZUMAB; RISK;
D O I
10.1016/j.soard.2020.06.011
中图分类号
R61 [外科手术学];
学科分类号
摘要
Tocilizumab, a monoclonal antiinterluekin-6 receptor antibody, has been empirically used in the treatment of cytokine release syndrome associated with severe coronavirus disease 2019 infections. The efficacy and safety of these medications for these patients is unknown. The purpose of this report was to present a case of acute large bowel perforation in a morbidly obese patient with coronavirus disease 2019 pneumonia who received empiric Tocilizumab. This case report analyzes the risks of acute large bowel perforation after using this medication empirically and discusses the appropriate management of this adverse event. (C) 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1372 / 1375
页数:4
相关论文
共 22 条
  • [1] Surgery during the COVID-19 pandemic: A comprehensive overview and perioperative care
    Al-Balas, Mahmoud
    Al-Balas, Hasan Ibrahim
    Al-Balas, Hamzeh
    [J]. AMERICAN JOURNAL OF SURGERY, 2020, 219 (06) : 903 - 906
  • [2] The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
    Arnaldez, Fernanda, I
    O'Day, Steven J.
    Drake, Charles G.
    Fox, Bernard A.
    Fu, Bingqing
    Urba, Walter J.
    Montesarchio, Vincenzo
    Weber, Jeffrey S.
    Wei, Haiming
    Wigginton, Jon M.
    Ascierto, Paolo Antonio
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [3] Anticoagulation in COVID-19
    Atallah, Bassam
    Mallah, Saad I.
    AlMahmeed, Wael
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (04) : 260 - 261
  • [4] Barie PS, 1996, ARCH SURG-CHICAGO, V131, P37
  • [5] COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
    Bikdeli, Behnood
    Madhavan, Mahesh V.
    Jimenez, David
    Chuich, Taylor
    Dreyfus, Isaac
    Driggin, Elissa
    Der Nigoghossian, Caroline
    Ageno, Walter
    Madjid, Mohammad
    Guo, Yutao
    Tang, Liang V.
    Hu, Yu
    Giri, Jay
    Cushman, Mary
    Quere, Isabelle
    Dimakakos, Evangelos P.
    Gibson, C. Michael
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    Fareed, Jawed
    Caprini, Joseph A.
    Tafur, Alfonso J.
    Burton, John R.
    Francese, Dominic P.
    Wang, Elizabeth Y.
    Falanga, Anna
    McLintock, Claire
    Hunt, Beverley J.
    Spyropoulos, Alex C.
    Barnes, Geoffrey D.
    Eikelboom, John W.
    Weinberg, Ido
    Schulman, Sam
    Carrier, Marc
    Piazza, Gregory
    Beckman, Joshua A.
    Steg, Gabriel
    Stone, Gregg W.
    Rosenkranz, Stephan
    Goldhaber, Samuel Z.
    Parikh, Sahil A.
    Monreal, Manuel
    Krumholz, Harlan M.
    Konstantinides, Stavros V.
    Weitz, Jeffrey I.
    Lip, Gregory Y. H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (23) : 2950 - 2973
  • [6] COVID-19 outbreak: Migration, effects on society, global environment and prevention
    Chakraborty, Indranil
    Maity, Prasenjit
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 728
  • [7] COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission
    Gu, Jinyang
    Han, Bing
    Wang, Jian
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : 1518 - 1519
  • [8] Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]
  • [9] Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
    Klopfenstein, T.
    Zayet, S.
    Lohse, A.
    Balblanc, J-C
    Badie, J.
    Royer, P-Y
    Toko, L.
    Mezher, C.
    Kadiane-Oussou, N. J.
    Bossert, M.
    Bozgan, A-M
    Charpentier, A.
    Roux, M-F
    Contreras, R.
    Mazurier, I
    Dussert, P.
    Gendrin, V
    Conrozier, T.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (05): : 397 - 400
  • [10] Rapid review for the anti-coronavirus effect of remdesivir
    Li, Ziyi
    Wang, Xiaojie
    Cao, Donglin
    Sun, Ruilin
    Li, Cheng
    Li, Guowei
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2020, 14 (02) : 73 - 76